Barclays’s Juno Therapeutics, Inc. JUNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-124,704
| Closed | -$5.7M | – | 4566 |
|
|
2017
Q4 | $5.7M | Sell |
124,704
-112,383
| -47% | -$5.14M | ﹤0.01% | 830 |
|
|
2017
Q3 | $10.6M | Buy |
237,087
+212,474
| +863% | +$9.53M | 0.01% | 551 |
|
|
2017
Q2 | $736K | Buy |
24,613
+20,911
| +565% | +$625K | ﹤0.01% | 1711 |
|
|
2017
Q1 | $82K | Sell |
3,702
-19,087
| -84% | -$423K | ﹤0.01% | 2923 |
|
|
2016
Q4 | $429K | Buy |
22,789
+17,743
| +352% | +$334K | ﹤0.01% | 1902 |
|
|
2016
Q3 | $151K | Sell |
5,046
-20,301
| -80% | -$608K | ﹤0.01% | 2262 |
|
|
2016
Q2 | $975K | Sell |
25,347
-37,092
| -59% | -$1.43M | ﹤0.01% | 1450 |
|
|
2016
Q1 | $2.37M | Buy |
62,439
+59,349
| +1,921% | +$2.26M | ﹤0.01% | 989 |
|
|
2015
Q4 | $134K | Buy |
3,090
+1,097
| +55% | +$47.6K | ﹤0.01% | 2204 |
|
|
2015
Q3 | $80K | Sell |
1,993
-6,511
| -77% | -$261K | ﹤0.01% | 2444 |
|
|
2015
Q2 | $450K | Buy |
8,504
+8,296
| +3,988% | +$439K | ﹤0.01% | 1809 |
|
|
2015
Q1 | $13K | Buy |
+208
| New | +$13K | ﹤0.01% | 3288 |
|